Randomized pilot study comparing oral ibuprofen with intravenous ibuprofen in very low birth weight infants with patent ductus arteriosus

Pediatrics

Volumn 122, Issue 6, 2008, Pages

  Cherif, Ahmed ^a,b   Khrouf, Naima ^a   Jabnoun, Sami ^a   Mokrani, Chahnez ^a   Amara, Moez Ben ^a   Guellouze, Nedia ^a   Kacem, Samia ^a  

^a UNIVERSITY OF TUNIS   (Tunisia)

^b Centre de Maternite et de Neonatologie Tunis   (Tunisia)

Author keywords

Ductus arteriosus; Ibuprofen; Premature infant

Indexed keywords

AMIKACIN; AMPICILLIN; CEFOTAXIME; CREATININE; DOPAMINE; FUROSEMIDE; IBUPHIL; IBUPROFEN; NITRIC OXIDE; PORACTANT; SURFACTANT; UNCLASSIFIED DRUG; NONSTEROID ANTIINFLAMMATORY AGENT;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; ECHOCARDIOGRAPHY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITAL INFECTION; HUMAN; INTESTINE PERFORATION; KIDNEY FAILURE; LIGATION; LOADING DRUG DOSE; LUNG EDEMA; MAJOR CLINICAL STUDY; MALE; NECROTIZING ENTEROCOLITIS; NEWBORN; PATENT DUCTUS ARTERIOSUS; PILOT STUDY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; REPEATED DRUG DOSE; SEPSIS; SINGLE DRUG DOSE; UREA NITROGEN BLOOD LEVEL; VERY LOW BIRTH WEIGHT; COMPARATIVE STUDY; DOPPLER ECHOCARDIOGRAPHY; DOSE RESPONSE; DRUG ADMINISTRATION; ECHOGRAPHY; FOLLOW UP; INTRAVENOUS DRUG ADMINISTRATION; NEWBORN INTENSIVE CARE; NONPARAMETRIC TEST; ORAL DRUG ADMINISTRATION; PROBABILITY; PROSPECTIVE STUDY; RISK ASSESSMENT; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY, DOPPLER, COLOR; FEMALE; FOLLOW-UP STUDIES; HUMANS; IBUPROFEN; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; INFUSIONS, INTRAVENOUS; INTENSIVE CARE UNITS, NEONATAL; MALE; PILOT PROJECTS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SINGLE-BLIND METHOD; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 58249089653     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2008-1780     Document Type: Article

References (30)

1. The Vermont-Oxford Trials Network. Very low birth weight outcomes for 1990. Pediatrics. 1993;91(3):540-545
2. Gersony WM, Peckham GJ, Ellison RC, Miettinen OS, Nadas AS. Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr. 1983;102(6):895-906
3. Cotton RB, Stahlman MT, Bender HW, Graham TP, Catterton WZ, Kovar I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr. 1978;93(4):647-651
4. Weir FJ, Ohlsson A, Myhr TL, Fong K, Ryan ML. A patent ductus arteriosus is associated with reduced middle cerebral artery blood flow velocity. Eur J Pediatr. 1999;158(6):484-487
5. Cherif A, Jabnoun S, Khrouf N. Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants. Am J Perinatol. 2007;24(6):339-345
6. Van Overmeire B, Smets K, Lecoutere D, et al. A comparison of ibuprofen and indomethacin for closure of patent ductus arteriosus. N Engl J Med. 2000;343(10):674-681
7. Papile LS, Burstein J, Burstein R, Koffler H. Incidence and evolution of the subependymal intraventricular hemorrhage: a study of infants weighing less than 1500 grams. J Pediatr. 1978;92(4):529-534
8. de Vries LS, Eken P, Dubowitz LM. The spectrum of leukomalacia using cranial ultrasound. Behav Brain Res. 1992;49(1):1-6
9. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based on clinical staging. Ann Surg. 1978;187(1):1-7
10. Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am J Perinatol. 2001;18(1):1-9
11. Lago P, Bettiol T, Salvadori S, et al. Safety and efficacy of ibuprofen versus indomethacin in preterm infants treated for patent ductus arteriosus: a randomised controlled trial. Eur J Pediatr. 2002;161(4):202-207
12. Hariprasad P, Sundarrajan V, Srimathy G, Suthager B, Ra-madevi BS. Oral ibuprofen for closure of hemodynamically significant PDA in premature neonates. Indian Pediatr. 2002;39(1):99-100
13. Supapannachart S, Limrungsikul A, Khowsathit P. Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital. J Med Assoc Thai. 2002;85(suppl 4):S1252-S1258
14. Aly H, Lotfy W, Badrawi N, Ghawas M, Abdel-Meguid IE, Hammad TA. Oral ibuprofen and ductus arteriosus in premature infants: a randomized pilot study. Am J Perinatol. 2007;24(5):267-270
15. Chotigeat U, Jirapapa K, Layangkool T. A comparison of oral ibuprofen and intravenous indomethacin for closure of patent ductus arteriosus in preterm infants. J Med Assoc Thai. 2003;86(suppl 3):S563-S569
16. Fakhraee SH, Badiee Z, Mojtahedzadeh S, Kazemian M, Kel-ishad R. Comparison of oral ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Zhongguo Dang Dai Er Ke Za Zhi. 2007;9(5):399-403
17. Heyman E, Morag I, Batash D, Keidar R, Baram S, Berkovitch. Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study. Pediatrics. 2003;112(5). Available at: www.pediatrics.org/ cgi/content/full/112/5/e354
18. Sangtawesin V, Sangtawesin C, Raksasinborisut C, et al. Oral ibuprofen prophylaxis for symptomatic patent ductus arteriosus of prematurity. J Med Assoc Thai. 2006;89(3):314-321
19. Raju NV, Bharadwaj RA, Thomas R, Konduri GG. Ibuprofen use to reduce the incidence and severity of bronchopulmonary dysplasia: a pilot study. J Perinatol. 2000;20(1):13-16
20. Sharma PK, Garg SK, Narang A. Pharmacokinetics of oral ibuprofen in premature infants. J Clin Pharmacol. 2003;43(9):968-973
21. Aranda JV, Varvarigou A, Beharry K, et al. Pharmacokinetics and protein binding of intravenous ibuprofen in the premature infant. Acta Paediatr. 1997;86(3):289-293
22. Varvarigou A, Bardin CL, Beharry K, Chemtob S, Papageorgiou A, Aranda JV. Early ibuprofen administration to preventpatent ductus arteriosus in premature newborn infants. JAMA. 1996;275(7):539-544
23. Desfrere L, Zohar S, Morville P, et al. Dose-finding study of ibuprofen in patent ductus arteriosus using the continual re-assessment method. J Clin Pharm Ther. 2005;30(2):121-132 24. De Carolis MP, Romagnoli C, Polimeni V, et al. Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants. Eur J Pediatr. 2000;159(5):364-368 (7)
24. Van Overmeire B, Allegaert K, Casaer A, et al. Prophylactic ibuprofen in premature infants: a multicentre, randomized, double blind, placebo-controlled trial. Lancet. 2004;364(9449): 1945-1949
25. Gournay V, Roze JC, Kuster A, et al. Prophylactic ibuprofen versus placebo in very premature infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2004;364(9449):1939-1344
26. Su PH, Chen JY, Su CM, Huang TC, Lee HS. Comparison of ibuprofen and indomethacin therapy for patent ductus arteriosus in preterm infants. Pediatr Int. 2003;45(6):665-670
27. Patel J, Roberts I, Azzopardi D, Hamilton P, Edwards AD. Randomized double-blind controlled trial comparing the effects of ibuprofen with indomethacin on cerebral hemodynamics in preterm infants with patent ductus arteriosus. Pediatr Res. 2000;47(1):36-42
28. Tiker F, Yildirim SV. Acute renal impairment after oral ibuprofen for medical closure of patent ductus arteriosus. Indian Pediatr. 2007;44(1):54-55
29. Tatli MM, Kumral A, Duman N, Demir K, Gurcu O, Ozkan H. Spontaneous intestinal perforation after oral ibuprofen treatment of patent ductus arteriosus in 2 very low birth weight infants. Acta Paediatr. 2004;93(7):999-1001
30. Pereira-da-Silva L, Pita A, Virella D, et al. Oral ibuprofen for patent ductus arteriosus closure in preterm infants: does high osmolality matter? Am J Perinatol. 2008;25(5):319-320